Next Article in Journal
Functional and Molecular Changes of the Bladder in Rats with Crushing Injury of Nerve Bundles from Major Pelvic Ganglion to the Bladder: Role of RhoA/Rho Kinase Pathway
Next Article in Special Issue
Spin Polarization and Quantum Spins in Au Nanoparticles
Previous Article in Journal
Quorum Quenching Enzymes and Their Application in Degrading Signal Molecules to Block Quorum Sensing-Dependent Infection
Previous Article in Special Issue
Tuning the Magnetic Properties of Nanoparticles
Open AccessArticle

Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia

1
Department of Materials Science & Engineering, University of Florida, Gainesville, FL 32611-6400, USA
2
Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611-6131, USA
3
Institute for Cell Engineering and Regenerative Medicine, University of Florida, Gainesville, FL 32611-6131, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(9), 17501-17510; https://doi.org/10.3390/ijms140917501
Received: 26 June 2013 / Revised: 5 August 2013 / Accepted: 21 August 2013 / Published: 26 August 2013
(This article belongs to the Special Issue Magnetic Nanoparticles 2013)
Feraheme, is a recently FDA-cleared superparamagnetic iron oxide nanoparticle (SPION)-based MRI contrast agent that is also employed in the treatment of iron deficiency anemia. Feraheme nanoparticles have a hydrodynamic diameter of 30 nm and consist of iron oxide crystallites complexed with a low molecular weight, semi-synthetic carbohydrate. These features are attractive for other potential biomedical applications such as magnetic fluid hyperthermia (MFH), since the carboxylated polymer coating affords functionalization of the particle surface and the size allows for accumulation in highly vascularized tumors via the enhanced permeability and retention effect. This work presents morphological and magnetic characterization of Feraheme by transmission electron microscopy (TEM), Energy dispersive X-ray spectroscopy (EDX), and superconducting quantum interference device (SQUID) magnetometry. Additionally, the results of an initial evaluation of the suitability of Feraheme for MFH applications are described, and the data indicate the particles possess promising properties for this application. View Full-Text
Keywords: Feraheme; magnetic fluid hyperthermia; magnetic nanoparticles; MRI contrast Feraheme; magnetic fluid hyperthermia; magnetic nanoparticles; MRI contrast
MDPI and ACS Style

Bullivant, J.P.; Zhao, S.; Willenberg, B.J.; Kozissnik, B.; Batich, C.D.; Dobson, J. Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia. Int. J. Mol. Sci. 2013, 14, 17501-17510.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop